The Signia Styletto C&G IX is a premium prescription hearing aid released in 2024, priced at $4,398. In HearAdvisor's lab testing, it earned a SoundScore of 4.56/5 and an A grade, placing it among the top performers in the prescription hearing aid category.
This behind-the-ear device delivers strong speech understanding performance, measuring well above average in both quiet and noisy environments. Own-voice comfort is a particular strength, scoring nearly a full point above the category average—a notable advantage for wearers sensitive to the sound of their own voice. The Styletto's distinctive slim design doesn't compromise its core hearing performance.
However, the device showed below-average feedback handling in our standardized testing, scoring more than a point below the category mean. Music streaming quality was slightly below average as well. These trade-offs are worth considering, particularly for users who prioritize feedback stability or frequently stream audio content.
At the premium price point, buyers have competitive alternatives. The Oticon Intent and Phonak Sphere Infinio both scored higher in our testing at similar prices. For those seeking comparable sound performance at a lower cost, the Rexton Reach R-Li T80 available at Costco ($1,499.99) and the Lexie B2 Plus ($999) offer strong value. The Styletto C&G IX is best suited for users who prioritize speech clarity and own-voice comfort, appreciate its award-winning design, and have access to skilled professional fitting.
